Mast cell chymase has a negative impact on human osteoblasts.

Area of Science:

• Cell Biology
• Bone Biology
• Biochemistry

Background:

• Mast cells are implicated in osteoporosis and bone fractures.
• Mice lacking mast cell chymase exhibit increased bone mass, suggesting chymase regulates bone formation.
• The precise mechanisms by which mast cell chymase influences bone metabolism remain unclear.

Purpose of the Study:

• To investigate the hypothesis that mast cell chymase directly impacts osteoblast function.
• To elucidate the molecular mechanisms underlying chymase's effect on osteoblasts.

Main Methods:

• Treatment of human primary osteoblasts with chymase.
• Assessment of osteoblast morphology, collagen output, and fibronectin degradation.
• Analysis of gene expression, protein levels, and signaling pathways (TGFβ, OPG).
• Transcriptomic analysis and confirmation of protein expression.
• Investigation of chymase interaction with and uptake by osteoblasts.

Main Results:

• Chymase induced significant morphological changes in osteoblasts, including cell contraction and actin reorganization.
• Chymase reduced collagen output, degraded fibronectin, and activated pro-matrix metallopeptidase-2.
• Chymase preferentially affected TGFβ-associated signaling molecules and altered the expression of key genes in bone metabolism, including osteoprotegerin (OPG).
• Chymase was shown to interact with and be internalized by osteoblasts.

Conclusions:

• Mast cell chymase directly influences human osteoblast function.
• Chymase impacts osteoblast morphology, extracellular matrix production, and critical signaling pathways.
• These findings establish a functional link between mast cell chymase and osteoblast activity, highlighting chymase as a potential therapeutic target for metabolic bone diseases.